Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

by | May 19, 2025 11:15 pm | US Markets

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and navigate other challenges